key: cord-0970806-et9io3tw
authors: Fan, Bingwen Eugene; Ong, Kiat Hoe; Chan, Stephrene Seok Wei; Young, Barnaby Edward; Chong, Vanessa Cui Lian; Chen, Siew Ping Connie; Lim, Shu Ping; Lim, Geok Ping; Kuperan, Ponnudurai
title: Blood and blood product use during COVID‐19 infection
date: 2020-04-22
journal: Am J Hematol
DOI: 10.1002/ajh.25823
sha: 315c169f19fb4a01fabf94cd087c3629a0fe9017
doc_id: 970806
cord_uid: et9io3tw

nan

Patient 3 was a 64-year-old male with asthma, hypertension, hyperlipidemia and ischemic heart disease. He was admitted for severe COVID-19 pneumonia with ARDS and AKI requiring CRRT.

Veno-venous extracorporeal membrane oxygenation (ECMO) was initiated with no requirements for transfusions but was then abandoned when the patient developed major bleeding. Fresh frozen plasma (FFP) and pooled platelets were transfused but the patient succumbed to multi-organ failure. 

Maintaining a safe and adequate blood supply during the pandemic outbreak of coronavirus disease (COVID-19) WHO Interim guidance

Evidence for gastrointestinal infection of SARS-CoV-2

ISTH interim guidance on recognition and management of coagulopathy in COVID-19

Disaster preparedness in the blood bank

Viral attacks on the blood supply: the impact of severe acute respiratory syndrome in Beijing

We salute the efforts of all healthcare workers and the support of their families during this pandemic. We thank the Department of Hematology and Department of Laboratory Medicine, Blood Trans-

fusion Service, Tan Tock Seng Hospital for the support in the colla-